Variable
|
Patients without
10% increase
N=705
|
Patients with
10% increase
N=473
|
P-Value
|
Age, years |
58.5 (11.6) |
58.0 (11.6) |
0.5592 |
Male |
558 (79.2) |
331 (70.0) |
0.0003 |
Caucasian |
578 (82.0) |
384 (81.2) |
0.7273 |
Medical History |
|
|
|
Non-ischemic CM |
319 (45.3) |
266 (56.2) |
0.0002 |
NYHA Class III |
184 (26.1) |
117 (24.7) |
0.5989 |
Baseline EF, % |
26.54 (6.3) |
23.39 (6.7) |
<0.0001 |
Pulmonary disease |
110 (15.6) |
85 (18.0) |
0.2838 |
Never smoker |
185 (26.2) |
130 (27.5) |
0.7367 |
Hyperlipidemia |
403 (57.2) |
242 (51.2) |
0.0425 |
Hypertension |
365 (51.8) |
245 (51.8) |
0.9936 |
Stroke |
42 (5.96) |
23 (4.86) |
0.4198 |
Diabetes |
192 (27.2) |
124 (26.2) |
0.6989 |
NSVT |
146 (20.7) |
90 (19.0) |
0.4796 |
Syncope |
57 (8.09) |
30 (6.3) |
0.2623 |
QRS duration <120 ms |
326 (46.2) |
161 (34.0) |
<0.0001 |
Atrial fibrillation by ECG |
36 (5.11) |
35 (7.4) |
0.1050 |
Blood pressure - diastolic, mmHg |
70.86 (10.7) |
72.01 (11.6) |
0.0806 |
Blood pressure - systolic, mmHg |
119.3 (19.30) |
122.0 (19.6) |
0.0187 |
Pulse, beats/min |
73.25 (13.9) |
75.10 (14.4) |
0.0272 |
Sodium, mg/dl |
139.3 (3.1) |
139.3 (3.0) |
0.9226 |
Potassium, mEq/L |
4.4 (0.5) |
4.4 (0.4) |
0.5401 |
Ace inhibitor |
596 (84.5) |
396 (83.7) |
0.7058 |
Beta blocker |
503 (71.4) |
314 (66.4) |
0.0701 |
Digoxin |
490 (69.5) |
312 (66.0) |
0.2012 |
Diuretic (loop) |
566 (80.3) |
370 (78.2) |
0.3911 |
Spironolactone |
117 (16.6) |
85 (18.0) |
0.5395 |
Statins |
307 (43.6) |
180 (38.1) |
0.0606 |
Months from CHF diagnosis |
45.11 (50.1) |
32.46 (42.3) |
<0.0001 |